Marieke Verhoeven - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Marieke Verhoeven's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Marieke Verhoeven

Marieke Verhoeven

Verified

Senior Editor, Holland Herald

Amsterdam

Final Covers

Travel, Parenting, Lifestyle, News & Trends

Doesn’t Cover

Stocks, sports

Journalist Type

-

Seniority Positions

Medium Formats

-

Content

Total articles 12

  • One-third of amenorrheic transmasculine people on testosterone ovulate

    By Joyce D. Asseler, Amsterdam UMC, Amsterdam Reproduction, Marieke Verhoeven Verified| Cell Reports Medicine Verified Highlights•33% of amenorrheic TGD people on testosterone show recent ovulatory activity•These findings challenge the assumption that amenorrhea equals anovulation•Contraception remains vital for preventing pregnancy in this demographicSummaryTransmasculine people usually reach amenorrhea within 6 months of adequate testosterone treatment. It is often assumed that no ovulation occurs during amenorrhea.

    By Joyce D. Asseler, Amsterdam UMC, Amsterdam Reproduction, Marieke Verhoeven Verified · Cell Reports Medicine

    Feb. 22, 2024

  • Reproductive Outcomes of Women with Turner Syndrome Undergoing Oocyte Vitrification: A Retrospective Multicenter Cohort Study

    By Sapthami Nadesapillai, Femke Mol, Simone L. Broer, Marieke Verhoeven Verified| MDPI@ 1. IntroductionTurner syndrome (TS) is a genetic condition affecting one in 2500 girls [1]. The partial or complete loss of one sex chromosome causes premature ovarian insufficiency in the majority of girls with TS [2]. The accelerated loss of follicles in women with TS starts from 14 to 18 weeks of gestation and continues until the ovarian reserve is fully depleted, usually during childhood or early adolescence [3,4].

    By Sapthami Nadesapillai, Femke Mol, Simone L. Broer, Marieke Verhoeven Verified · MDPI

    Oct. 12, 2023

  • One-third of amenorrheic transmasculine people on testosterone ovulate

    By Joyce D. Asseler, Amsterdam UMC, Amsterdam Reproduction, Marieke Verhoeven Verified| Cell Reports Medicine Verified Highlights•33% of amenorrheic TGD people on testosterone show recent ovulatory activity•These findings challenge the assumption that amenorrhea equals anovulation•Contraception remains vital for preventing pregnancy in this demographicSummaryTransmasculine people usually reach amenorrhea within 6 months of adequate testosterone treatment. It is often assumed that no ovulation occurs during amenorrhea.

    By Joyce D. Asseler, Amsterdam UMC, Amsterdam Reproduction, Marieke Verhoeven Verified · Cell Reports Medicine

    Feb. 22, 2024

As seen in

Company Info

Holland Herald

Amsterdam, North Holland, Netherlands

+31 20 262 3000